Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melablock: Propranolol for Melanoma Recurrence
NCT02962947Phase 3Unknown
- Sponsor
- Azienda USL Toscana Centro
- Start
- Jun 2017
- Primary completion
- Jun 2019
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of propranolol in Malignant Melanoma (MM), sponsored by Azienda USL Toscana Centro. Status: unknown.
02
Drugs
propranolol
03
Conditions
Malignant Melanoma (MM)
Beyond the preview
Go deeper on NCT02962947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02962947.